Taccone, 1,747 patient HCQ ICU study: 25% lower mortality [p=0.02] https://c19p.org/taccone
copied to clipboard
The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium
et al., The Lancet Regional Health - Europe, doi:10.1016/j.lanepe.2020.100019
Retrospective 1,747 ICU patients in Belgium showing lower mortality with HCQ, multivariate mixed effects analysis HCQ aOR 0.64 [0.45-0.92].
|
risk of death, 24.7% lower, RR 0.75, p = 0.02, treatment 449 of 1,308 (34.3%), control 183 of 439 (41.7%), NNT 14, odds ratio converted to relative risk.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Taccone et al., 12/23/2020, retrospective, Belgium, Europe, peer-reviewed, 10 authors, average treatment delay 5.0 days.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.